AbbVie, Inc. (ABBV)
225.76
+2.68
(+1.20%)
USD |
NYSE |
Jun 09, 15:51
AbbVie Market Cap : 398.85B for June 9, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Biogen, Inc. | 29.32B |
| Gilead Sciences, Inc. | 155.86B |
| Regeneron Pharmaceuticals, Inc. | 64.65B |
| Travere Therapeutics, Inc. | 4.490B |
| Amgen, Inc. | 186.00B |
Market Cap Related Metrics
| PE Ratio | 111.35 |
| PS Ratio | 6.371 |
| Price to Free Cash Flow | 20.03 |
| Price | 225.76 |
| Earnings Yield | 0.90% |
| Operating PE Ratio | 18.97 |
| Normalized PE Ratio | 30.85 |